Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,445 | 27,914 | 34,475 | 37,453 | 48,850 |
| Marketable Securities | 52,808 | 40,141 | 62,553 | 29,230 | 26,089 |
| Receivables | 5,985 | 3,313 | 4,335 | 5,877 | 6,404 |
| Other current assets | 395 | 528 | -16,354 | 847 | 335 |
| TOTAL | $110,633 | $71,896 | $85,009 | $73,407 | $81,678 |
| Non-Current Assets | |||||
| PPE Net | 55,543 | 54,251 | 53,502 | 51,640 | 50,114 |
| Investments And Advances | 25,247 | 23,223 | 18,170 | 22,580 | 23,009 |
| Other Non-Current Assets | 101 | 103 | 100 | 927 | 1,248 |
| TOTAL | $80,891 | $77,577 | $71,772 | $75,147 | $74,371 |
| Total Assets | $169,954 | $129,068 | $137,581 | $130,600 | $139,272 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,077 | 3,417 | 2,170 | 4,230 | 4,247 |
| Accrued Expenses | 0 | 0 | 2,170 | 0 | 0 |
| Other current liabilities | 2,641 | 2,912 | 4,100 | 921 | 1,671 |
| TOTAL | $10,848 | $9,697 | $12,048 | $8,917 | $9,602 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,712 | 1,730 | N/A | 1,768 | 1,787 |
| aiOther Non-Current Liabilities | 214 | 198 | 180 | 164 | 144 |
| TOTAL | $19,162 | $18,328 | $16,850 | $17,458 | $16,869 |
| Total Liabilities | $30,010 | $28,025 | $30,650 | $26,375 | $26,471 |
| Shareholders' Equity | |||||
| Common Shares | 26 | 26 | 20 | 22 | 25 |
| Retained earnings | -167,227 | -162,958 | N/A | -148,886 | -139,997 |
| Other shareholders' equity | -759 | -874 | -157,829 | -1,057 | -1,285 |
| TOTAL | $139,944 | $101,043 | $106,931 | $104,225 | $112,801 |
| Total Liabilities And Equity | $169,954 | $129,068 | $137,581 | $130,600 | $139,272 |